Abbott To Pull Meridia In US Over Heart Risks

Law360, New York (October 8, 2010, 2:35 PM EDT) -- Federal regulators announced Friday that Abbott Laboratories had agreed to take diet drug Meridia off the market because of results from a clinical study showing it increases the risk of heart attack or stroke.

The U.S. Food and Drug Administration asked Abbott to withdraw the obesity drug after reviewing data from a post-marketing study that found Meridia increased by 16 percent the risk of serious heart events, which also included the need for resuscitation after heart stoppage.

Abbott pointed out Friday that the majority of the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.